The plan to create one or two stem cell
genomics centers in California at a cost of $40 million began in
2012. Since then there have been some changes, some of which resulted
from the failure of reviewers to recommend any proposals in 2013.
Last week, the California Stem Cell
Report (CSCR) asked the California stem cell agency(CIRM), which is
scheduled to make a decision today on an at least one application,
about several of the changes. Here are the texts of the questions and
answers from the agency.
CSCR: Has the cast of applicants
changed since the initial review in early 2013? Have some dropped out
or been added? Have the applications been recast significantly for
the most recent review?
CIRM: Applicants to the first round of
review were eligible to participate in the second round. Although
review criteria remained the same as those stated in the RFA,
applicants were allowed to change proposal components, establish new
collaborations and/or combine efforts.
CSCR: How many letters of intent
(LOI) were received with a breakdown on the number from academic and
business enterprises? How many applications were received, also
with a breakdown on academic and business?
CIRM: For the first round, there were 9
LOI's; 7 of these submitted applications. No LOI was required
for the second round. All first round applicants participated
in the second round of competition, but several have combined
efforts, so there were 5 applications in the second round. Three
of these applications were collaborative proposals combining both
for-profit and not-for-profit organizations, while the other two were
from not-for-profit institutions.
No comments:
Post a Comment